Type 1 Diabetes Leukopak
About:Type 1 Diabetes Leukopak is sourced from consented donors with documented diabetes type i. These samples support immune-cell research, with donor information on condition, demographics, medications and comorbidities.
About Type 1 Diabetes Leukopak
Type 1 Diabetes Leukopak is sourced from consented donors with documented diabetes type i. These samples support immune-cell research, with donor information on condition, demographics, medications and comorbidities.
Applications
- Diabetes Type I research
- Immune-cell phenotyping
- Downstream immune-cell isolation studies
- Cellular functional assays
- Translational immunology research
Product Features
- Human leukopak material
- Donor condition: Diabetes Type I
- Consented donor collection
- Research Use Only (RUO)
De-identified Donor Data
- Donor condition/diagnosis and documented clinical phenotype
- Age, gender and race/ethnicity
- Medications and comorbidities
- HLA typing and CMV status
- HIV, HBV, HCV and syphilis testing
- ABO/Rh blood type and country of collection
- Tobacco, alcohol, caffeine and recreational drug use
Donor Stratification
Cohort characteristics include diagnosis and documented clinical phenotype, medication history, comorbidities and demographics.
Processing specifications
- Anticoagulant
- Confirmed per lot on request
- Formats
- Cryopreserved, FreshBag sizesFull BagHalf Bag
- Processing window
- Processed within 24 hours of collection unless otherwise stated
- Cryopreservation
- Plasma-reduced; serum-free freezing medium with 10% DMSO; controlled-rate freezer
- Storage
- Vapor-phase liquid nitrogen
- Count and viability
- Total nucleated cell count and viability by AO/PI on a dual-fluorescence counter
From Sanguine's processing protocols. View protocols
Donor and clinical data in these lots
Fields recorded on the 3 in-stock lots for this product. Coverage varies by donor; blank fields are not available for that lot.
Donor
- Sex
- 3 of 3 lots
- Age
- 3 of 3 lots
- Race
- 3 of 3 lots
- BMI
- 3 of 3 lots
Clinical history
- Primary diagnosis
- 3 of 3 lots
- Current medications
- 3 of 3 lots
- Allergies
- 3 of 3 lots
- Infectious disease history
- 3 of 3 lots
Lab results & genotype
- CMV serostatus
- 2 of 3 lots
- ABO / Rh blood type
- 2 of 3 lots
- HLA class I typing
- 2 of 3 lots
- HLA class II typing
- 1 of 3 lots
Lifestyle
- Tobacco use
- 3 of 3 lots
- Alcohol use
- 3 of 3 lots
- Recreational drug use
- 3 of 3 lots
- Caffeine use
- 3 of 3 lots
Collection
- Collection date
- 3 of 3 lots
- Country of collection
- 3 of 3 lots
Need a field that isn't listed, such as disease stage or time since diagnosis?
Shipping terms
Ships frozen on dry ice from the US. International orders welcome.
Domestic
- Rates
- Shipped frozen on dry ice by overnight courier. $411 per order up to $8,000; $935 above $8,000. Leukopaks: $935 per cryopreserved bag, $550 per fresh bag. Fresh whole blood: $216 per 3 healthy donors or per disease-state donor.
- Dispatch
- In-stock samples ship in 2 business days.
- Own courier account
- You can ship on your own courier account. You bear all transit risk and must declare the full value of the shipment.
International
- Rates
- $750 per order, shipped on dry ice by a courier designated by Sanguine unless you ask for an alternative.
- Title and risk
- Title and risk pass to you when the shipment is handed to the carrier (Incoterms 2020 EXW).
- Permits, customs and duties
- You are responsible for import permits, customs clearance, duties and taxes, and for complying with the export and import laws that apply to you.
- Delays
- Sanguine is not responsible for delays caused by carriers, customs, or external events.
- Own courier account
- You can ship on your own courier account. You bear all transit risk and must declare the full value of the shipment.
More detail on our shipping charges page.
Quality and protocols
-
Download
Leukopak Cryopreservation
Standard operating procedure for cryopreserving leukopak units with controlled freezing and post-thaw viability targets.
-
Download
Leukopak Thawing
Validated thawing workflow for cryopreserved leukopaks to maximize recovery while maintaining sterility and chain of custody.
-
Download
Choosing the Right PBMC Configuration
Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
Leukopak
Where can I find your complete catalog?
You can find our full product catalog here.
How long can samples be stored?
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
What customization options are available?
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
Do you offer prospective collections?
Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.
What is the turnaround time for custom collections?
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
Do you have samples in stock?
YES - we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
What does unique donor mean?
Each sample from a different individual - Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
Are samples collected under IRB-approved protocols?
YES - "IRB-approved collection protocols" and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Frequently Asked Questions
Ask a Question
Pair with a Healthy Control
Match your Type 1 Diabetes Leukopak with normal donor samples for comparison
Healthy Donor Leukopaks
7 In Stock View InventoryNeed a custom Leukopak cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.